These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25252752)

  • 1. Predictive value for death and rehospitalization of 30-day postdischarge B-type natriuretic peptide (BNP) in elderly patients with heart failure. Sub-analysis of Italian RED Study.
    Di Somma S; Marino R; Zampini G; Magrini L; Ferri E; Shah K; Clopton P; Maisel AS
    Clin Chem Lab Med; 2015 Feb; 53(3):507-13. PubMed ID: 25252752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of combining admission brain natriuretic peptide (BNP) plus hospital discharge bioelectrical impedance vector analysis (BIVA) in predicting 90 days cardiovascular mortality in patients with acute heart failure.
    Santarelli S; Russo V; Lalle I; De Berardinis B; Navarin S; Magrini L; Piccoli A; Codognotto M; Castello LM; Avanzi GC; Villacorta H; Precht BLC; de Araújo Porto PB; Villacorta AS; Di Somma S;
    Intern Emerg Med; 2017 Jun; 12(4):445-451. PubMed ID: 27987064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath.
    Maisel A; Hollander JE; Guss D; McCullough P; Nowak R; Green G; Saltzberg M; Ellison SR; Bhalla MA; Bhalla V; Clopton P; Jesse R;
    J Am Coll Cardiol; 2004 Sep; 44(6):1328-33. PubMed ID: 15364340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure.
    Valle R; Aspromonte N; Giovinazzo P; Carbonieri E; Chiatto M; di Tano G; Feola M; Milli M; Fontebasso A; Barro S; Bardellotto S; Milani L
    J Card Fail; 2008 Apr; 14(3):219-24. PubMed ID: 18381185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-hospital percentage BNP reduction is highly predictive for adverse events in patients admitted for acute heart failure: the Italian RED Study.
    Di Somma S; Magrini L; Pittoni V; Marino R; Mastrantuono A; Ferri E; Ballarino P; Semplicini A; Bertazzoni G; Carpinteri G; Mulè P; Pazzaglia M; Shah K; Maisel A; Clopton P
    Crit Care; 2010; 14(3):R116. PubMed ID: 20550660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.
    Nishii M; Inomata T; Takehana H; Naruke T; Yanagisawa T; Moriguchi M; Takeda S; Izumi T
    J Am Coll Cardiol; 2008 Jun; 51(24):2329-35. PubMed ID: 18549918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different trajectories and significance of B-type natriuretic peptide, congestion and acute kidney injury in patients with heart failure.
    Beltrami M; Ruocco G; Ibrahim A; Lucani B; Franci B; Nuti R; Palazzuoli A
    Intern Emerg Med; 2017 Aug; 12(5):593-603. PubMed ID: 28181125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure.
    Logeart D; Thabut G; Jourdain P; Chavelas C; Beyne P; Beauvais F; Bouvier E; Solal AC
    J Am Coll Cardiol; 2004 Feb; 43(4):635-41. PubMed ID: 14975475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
    J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discharge BNP is a stronger predictor of 6-month mortality in acute heart failure compared with baseline BNP and admission-to-discharge percentage BNP reduction.
    Omar HR; Guglin M
    Int J Cardiol; 2016 Oct; 221():1116-22. PubMed ID: 27467969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How often we need to measure brain natriuretic peptide (BNP) blood levels in patients admitted to the hospital for acute severe heart failure? Role of serial measurements to improve short-term prognostic stratification.
    Faggiano P; Valle R; Aspromonte N; D'Aloia A; Di Tano G; Barro S; Giovinazzo P; Milani L; Lorusso R; Dei Cas L
    Int J Cardiol; 2010 Apr; 140(1):88-94. PubMed ID: 19321212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additive diagnostic and prognostic value of bioelectrical impedance vector analysis (BIVA) to brain natriuretic peptide 'grey-zone' in patients with acute heart failure in the emergency department.
    Di Somma S; Lalle I; Magrini L; Russo V; Navarin S; Castello L; Avanzi GC; Di Stasio E; Maisel A
    Eur Heart J Acute Cardiovasc Care; 2014 Jun; 3(2):167-75. PubMed ID: 24477201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-type natriuretic peptide may predict prognosis in older adults admitted with a diagnosis other than heart failure.
    Di Marca S; Rando A; Cataudella E; Pulvirenti A; Alaimo S; Terranova V; Corriere T; Pisano M; Di Quattro R; Ronsisvalle ML; Giraffa CM; Giordano M; Stancanelli B; Malatino L
    Nutr Metab Cardiovasc Dis; 2018 Jun; 28(6):636-642. PubMed ID: 29625779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of short-term follow-up BNP in hospitalized patients with heart failure.
    Khanam SS; Son JW; Lee JW; Youn YJ; Yoon J; Lee SH; Kim JY; Ahn SG; Ahn MS; Yoo BS
    BMC Cardiovasc Disord; 2017 Aug; 17(1):215. PubMed ID: 28774268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of the use of B-type natriuretic peptide levels for risk stratification at discharge in elderly patients with decompensated heart failure.
    Cournot M; Mourre F; Castel F; Ferrières J; Destrac S
    Am Heart J; 2008 Jun; 155(6):986-91. PubMed ID: 18513508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of hand-carried ultrasound assessment of the inferior vena cava and N-terminal pro-brain natriuretic peptide for predicting readmission after hospitalization for acute decompensated heart failure.
    Goonewardena SN; Gemignani A; Ronan A; Vasaiwala S; Blair J; Brennan JM; Shah DP; Spencer KT
    JACC Cardiovasc Imaging; 2008 Sep; 1(5):595-601. PubMed ID: 19356487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea.
    Harrison A; Morrison LK; Krishnaswamy P; Kazanegra R; Clopton P; Dao Q; Hlavin P; Maisel AS
    Ann Emerg Med; 2002 Feb; 39(2):131-8. PubMed ID: 11823766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic combined role of B-type natriuretic peptide, blood urea nitrogen and congestion signs persistence in patients with acute heart failure.
    Ruocco G; Pellegrini M; De Gori C; Franci B; Nuti R; Palazzuoli A
    J Cardiovasc Med (Hagerstown); 2016 Nov; 17(11):818-27. PubMed ID: 26702597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary results of the HABIT Trial (heart failure assessment with BNP in the home).
    Maisel A; Barnard D; Jaski B; Frivold G; Marais J; Azer M; Miyamoto MI; Lombardo D; Kelsay D; Borden K; Iqbal N; Taub PR; Kupfer K; Clopton P; Greenberg B
    J Am Coll Cardiol; 2013 Apr; 61(16):1726-35. PubMed ID: 23500322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk stratification with the use of serial N-terminal pro-B-type natriuretic peptide measurements during admission and early after discharge in heart failure patients: post hoc analysis of the PRIMA study.
    Eurlings LW; Sanders-van Wijk S; van Kraaij DJ; van Kimmenade R; Meeder JG; Kamp O; van Dieijen-Visser MP; Tijssen JG; Brunner-La Rocca HP; Pinto YM
    J Card Fail; 2014 Dec; 20(12):881-90. PubMed ID: 25175696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.